Evidence map›Paper›PMID 37280225›Full record

ArticleNature communications2023

Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation.

Lin Du, Bo Man Ho, Linbin Zhou, Yolanda Wong Ying Yip, Jing Na He, Yingying Wei, Clement C Tham, Sun On Chan, Andrew V Schally, Chi Pui Pang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Somatostatin analogs in endothelial dysfunction.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. GHRH in diabetes and metabolism.Reviews in endocrine & metabolic disorders · 2025
    Review
  13. Growth hormone - releasing hormone in the immune system.Reviews in endocrine & metabolic disorders · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Lin DuDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Bo Man HoDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0001-7386-3868
Linbin ZhouDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Yolanda Wong Ying YipDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Jing Na HeDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Yingying WeiDepartment of Statistics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Clement C ThamDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0003-4407-6907
Sun On ChanSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0002-3221-3786
Andrew V SchallyEndocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, Miami, FL, USA.
Chi Pui PangDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Jian LiDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong. lijian@link.cuhk.edu.hk.ORCID 0000-0002-1153-1435
Wai Kit ChuDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong. waikit@cuhk.edu.hk.ORCID 0000-0003-2903-3247
Chinese University of Hong Kong · HKUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of Th17 cell differentiation and pathogenicity contributes to multiple autoimmune and inflammatory diseases. Previously growth hormone releasing hormone receptor (GHRH-R) deficient mice have been reported to be less susceptible to the induction of experimental autoimmune encephalomyelitis. Here, we show GHRH-R is an important regulator of Th17 cell differentiation in Th17 cell-mediated ocular and neural inflammation. We find that GHRH-R is not expressed in naïve CD4

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalTh17 CellsAnimalsCell DifferentiationGrowth Hormone-Releasing HormoneInflammationMiceMice, Inbred C57BLSignal TransductionGrowth Hormone-Releasing Hormone

Identifiers

PMID37280225
PMCPMC10244428
OpenAlexW4379599816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.